Figures & data
Table 1. Distribution of the rat groups.
Table 2. Fracture healing scoring system.
Figure 1. Group I-A with simvastatin. New bone formation around the simvastatin with active connective tissue and rich neovascularisation structure (H&E × 200).
![Figure 1. Group I-A with simvastatin. New bone formation around the simvastatin with active connective tissue and rich neovascularisation structure (H&E × 200).](/cms/asset/bc84f29f-7736-4d80-b6de-9312d08aca68/tbeq_a_1416673_f0001_oc.jpg)
Figure 2. Group I-A without simvastatin. Osteoblasts, differentiated young mesenchymal stem cells and new secreted bone matrix (H&E × 400).
![Figure 2. Group I-A without simvastatin. Osteoblasts, differentiated young mesenchymal stem cells and new secreted bone matrix (H&E × 400).](/cms/asset/c1014b00-52b4-4d51-b7eb-8916b8050112/tbeq_a_1416673_f0002_oc.jpg)
Figure 3. Group II-A with simvastatin. New bone formation with active connective tissue and simvastatin particles (H&E x 100).
![Figure 3. Group II-A with simvastatin. New bone formation with active connective tissue and simvastatin particles (H&E x 100).](/cms/asset/970cd2a4-7cbb-4b0b-a0fb-cfe9494a123c/tbeq_a_1416673_f0003_oc.jpg)
Figure 4. Group II-A without simvastatin. Young and old bleeding areas in the active connective tissue and osteoblastic differentiated young mesenchymal stem cells (H&E × 100).
![Figure 4. Group II-A without simvastatin. Young and old bleeding areas in the active connective tissue and osteoblastic differentiated young mesenchymal stem cells (H&E × 100).](/cms/asset/8dc531f0-ac93-44bc-a820-877612e29aa9/tbeq_a_1416673_f0004_oc.jpg)
Table 3. Comparison of bone healing, inflammation, necrosis and fibrosis values on day 8.
Figure 5. Group I-B with simvastatin. Ice band like reticular bone formation between defect margins (H&E × 100).
![Figure 5. Group I-B with simvastatin. Ice band like reticular bone formation between defect margins (H&E × 100).](/cms/asset/f4ab5f02-f7be-4abd-ac93-bda91ce8c199/tbeq_a_1416673_f0005_oc.jpg)
Figure 6. Group I-B without simvastatin. Bridge-like new bone formation covering the defect (H&E × 100)
![Figure 6. Group I-B without simvastatin. Bridge-like new bone formation covering the defect (H&E × 100)](/cms/asset/f62902a7-c227-4687-b815-da1a2683bfee/tbeq_a_1416673_f0006_oc.jpg)
Figure 7. Group II-B with simvastatin. New bone trabecules filling the half of the defect around the simvastatin particles (H&E × 100).
![Figure 7. Group II-B with simvastatin. New bone trabecules filling the half of the defect around the simvastatin particles (H&E × 100).](/cms/asset/95c21e08-0282-4b1a-a4a5-8e833f69f372/tbeq_a_1416673_f0007_oc.jpg)
Table 4. Comparison of bone healing, inflammation, necrosis and fibrosis values on day 15.